Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Evista**

Evista** :
Type Medicine Non Marketed
Originator B
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Lilly
Responsible Party Eli Lilly & Co
Origin U.S.A.
Manufacturer Eli Lilly & Co
Origin U.S.A.
ATC G03XC01
Revision Date 30/08/2005

Your comment will appear shortly after approval

Evista** :

Revision Date :


Effect Frequency
Abdominal pain Very Common
Arterial thromboembolic reactions Uncommon
Blood pressure increased Very Common
Breast enlargement Common
Breast pain Common
Breast tenderness Common
Cephalea Common
Deep vein thrombosis Uncommon
Dyspepsia Very Common
Fatal stroke Uncommon
Flu Syndrome Very Common
Hot flush Very Common
Leg cramps Common
Migraine Common
Nausea Very Common
Oedema peripheral Common
Pulmonary embolism Uncommon
Retinal vein thrombosis Uncommon
Skin rash Common
Superficial vein thrombophlebitis Uncommon
Thrombocytopenia (Thrombopenia) Uncommon
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/06/2018

Revision Date : 30/08/2012

Evista**  MoH 3668 :
Form Tablet
Package Size Box of 30
Strength 60mg
Storage Condition <30°C Do not freeze
NSSF ✘
Quarantine ✘
Reg. Number 78872/98
Submission date 01/01/1998
Registration Year 1998
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info